Next Article in Journal
Candida Infections in Marine Mammals: Epidemiology, Antifungal Resistance, and One Health Implications
Previous Article in Journal
Development of an LC-MS/MS-Based Analytical Method, In Vitro Characterization, and Pharmacokinetic Study of Rafoxanide Nanosuspension in Sheep
Previous Article in Special Issue
Improving Clinical Diagnosis of Transmissible Spongiform Encephalopathies in Sheep: Which Signs Are Important?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prion Protein Codon Implicated in Resistance in Dogs Detected in Non-Domesticated Members of Mammalia

by
Emily A. Wright
1,*,
Vivienne A. Lacy
2,†,
Georgina G. Brugette
3,
Savannah M. Roberts
2,‡,
Emma K. Brookover
4,§,
Daniel M. Hardy
5 and
Robert D. Bradley
2,3
1
Independent Researcher, Rockwall, TX 75032, USA
2
Department of Biological Sciences, Texas Tech University, 2901 Main Street, Lubbock, TX 79409, USA
3
Natural Science Research Laboratory, Museum at Texas Tech University, 3301 4th Street, Lubbock, TX 79409, USA
4
Climate Center, Texas Tech University, Weeks Hall, 2508 Broadway Ave, Lubbock, TX 79409, USA
5
Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
*
Author to whom correspondence should be addressed.
Current address: Independent Researcher, 5820 Highland Park Drive, Fort Worth, TX 76132, USA.
Current address: Independent Researcher, 1412 Briar Meadow Drive, Keller, TX 76248, USA.
§
Current address: Caesar Kleberg Wildlife Research Institute, Texas A&M University–Kingsville, 700 University Blvd., MSC 218, Kingsville, TX 78363, USA.
Animals 2026, 16(7), 1059; https://doi.org/10.3390/ani16071059
Submission received: 5 February 2026 / Accepted: 27 March 2026 / Published: 31 March 2026
(This article belongs to the Special Issue Prion Diseases in Animals)

Simple Summary

We examined the genetic variation in exon 3 of the prion protein gene across mammals as it pertains to potential resistance (i.e., limited susceptibility) to prion disease. Previous research suggests that a single codon reported in canids, N163D/E, confers protection against prion diseases in vitro. We used bioinformatics and phylogenetic analyses to discover that two families in Carnivora (Canidae and Mustelidae) and Chiroptera (Mormoopidae and Vespertilionidae) and one family in Artiodactyla (Moschidae) and Rodentia (Erethrizontidae) possessed the N163D/E substitution. The comprehensive molecular survey herein for mammalian candidates that may display a lack of sensitivity to prion diseases presents an update to the ever-growing field of prion disease. In vitro studies are needed to include these other species to truly reveal their susceptibility to prion disease and the role of N163D/E in mammalian species.

Abstract

Transmissible spongiform encephalopathies (TSE) are fatal neurodegenerative diseases caused by the misfolding of proteins generated in the exon 3 region of the prion protein gene (PRNP). Recent investigations using protein misfolding cyclic amplification assays indicated that some canids displayed a low susceptibility to TSE due to a specific nonsynonymous substitution (human: N159D/E; canid: N163D/E; alignment herein: N302D/E) in the prion protein that may confer protection against prion seeding activity and propagation. To examine the molecular evolution underlying this observation, we determined the mammalian taxonomic distribution of the N159D/E substitution in 882 PRNP sequences representing 26 Orders, 132 families, and 686 species. Two families each in Carnivora (Canidae and Mustelidae) and Chiroptera (Mormoopidae and Vespertilionidae), and one family each in Artiodactyla (Moschidae) and Rodentia (Erethrizontidae), possessed N159D/E that has been reported to confer resistance to TSEs. Although no direct evidence linked a pattern of resistance (phylogenetic relatedness, geographic location, etc.) in these diverse species, it may be that coevolutionary pressures led 53 of the examined 686 species (1 domestic species, 52 wild species) to possess N159D/E. Therefore, the presence of N159D/E may not be the only factor in determining sensitivity to prion diseases; consequently, a more detailed investigation into the 53 species, such as knockout experiments, is warranted.

1. Introduction

Spongiform encephalopathies (SE) are fatal neurodegenerative diseases caused by a misfolding in the prion protein region encoded by exon 3 of the gene (PRNP). In humans, known prion diseases, including transmissible spongiform encephalopathies (TSE), are Creutzfeldt-Jakob disease (CJD), variant Creutzfeldt-Jakob disease, Kuru or Gertsmann-Sträussler-Scheinker disease (GSS), fatal and sporadic familial insomnia and variable protease-sensitive prionopathy (VPSPr) [1]. Several prion diseases have been identified in mammalian species, including scrapie in sheep and goats [2], chronic wasting disease (CWD) in cervids (deer species), bovine spongiform encephalopathy (BSE) in cattle, transmissible mink encephalopathy (TME), feline spongiform encephalopathy (FSE), and camel prion disease (CPD) [3,4,5,6,7,8].
The prion protein amino acid sequence (PrP) is highly conserved across mammalian species, with approximately 85% sequence identity to humans [9]. Substitutions in this highly conserved region may impact molecular folding processes and typically result in disease [10]. Normal cellular PrP (PrPC) is alpha-helical, whereas the infectious conformation (PrPSc) is richer in beta-sheets formed post-translationally. Further, the infectious PrPSc tend to aggregate, serve as a template for generating new PrPSc, and become resistant to proteases, leading to TSE [11].
The first recognized instance of prion disease crossing the species barrier to humans occurred in the United Kingdom in the 1990s, where variant bovine spongiform encephalopathy caused an epidemic from contamination of meat and bone meal containing scrapie, which was then accelerated by recycling infected bovine tissues [12]. Humans who consumed beef products from prion-infected cattle during this period were diagnosed with CJD. Recently, in wild and captive cervids, CWD has been increasing in frequency, raising concerns about managing this disease in wildlife species such as deer and elk [5,13]. Although transmission between cervids and humans has not yet been documented, there is a possible risk to human health in handling and consuming the potentially asymptomatic deer tissue [14,15].
Some mammalian species have been reported to possess varying levels of resistance to prion disease. For example, members of the mammalian families Canidae [16,17,18,19,20,21,22,23,24,25], Equidae [24,26,27,28,29], Leporidae [30,31], Mustelidae [20], and Suidae [32] have been shown to be highly resistant to prion diseases [33,34,35,36]. New Zealand White rabbits (Oryctolagus cuniculus) displayed a low susceptibility to prion disease demonstrated by in vitro experiments [37,38], whereas the prion protein associated with horses (Equus caballus) and dogs (Canis familiaris), respectively, were unaffected by these inoculation trials, indicating horses and dogs do not naturally contract the disease and subsequently are more resistant to the change in protein conformation [24,28,35].
Recent studies demonstrated that most members of Suborder Ruminantia (cattle, deer, goats, sheep, and allies) are highly susceptible to prion diseases, with codon positions at 136, 154, and 171 serving as important codons leading to the susceptibility of sheep to scrapie [39,40,41,42]. Some domestic sheep species with the R1 classification (genotype A136R154R171/A136R154R171) have been deliberately selected to be resistant to scrapie [6,43]. In addition, there is evidence suggesting that water buffalo (Bubalus bubalis) have low-level susceptibility to TSEs similar to that reported for rabbits, dogs, and horses [44].
Although the hypothesis of truly resistant mammals to prion diseases is contentious [37,45,46,47,48,49,50,51], mammals may have a low susceptibility to prion diseases based on data accrued from in vitro and in vivo challenges under highly favorable laboratory conditions, but never encounter or develop prion disease in nature [24,34,35]. Polymenidou et al. [17] explored the risk of replicating prions in Madin Darby canine kidney (MDCK, originally derived from Canis familiaris, breed: cocker spaniel) 33,016 cells, wherein these cells failed to induce prion infection using different strains of prion diseases. Polymenidou et al. [17] indicated that although there was no direct evidence that the canine PrPC (cPrPC) can convert into a pathological isoform, it is reasonable to assume they have been exposed to BSE-contaminated feed, and therefore probably are immune to infection. Further, Polymenidou et al. [20] reported low levels of expressed cPrPC and that it was not located on raft fractions, which was hypothesized to contribute to MDCK cells possessing an apparent resistance to prions. Further, Lysek et al. [16] used nuclear magnetic resonance (NMR) analyses to determine that the presence of D159 (numbering based on human PRNP) and R177 (numbering based on human PRNP) in dogs (C. familiaris) causes unique charge distribution patterns on the front and back side of cPrPC when compared to sheep and feline PrP. This variation in cPrPC structure may also correlate with the protection of C. familiaris against challenge with BSE. In addition, cPrPC possesses stable molecular structures under neutral and low pH environments [19].
In an attempt to discover the molecular basis for resistance, Stewart et al. [20] examined the PrPC sequences of 18 species, representative of the Suborder Caniformia, in which sequences representative of members of Canidae and Mustelidae possessed two substitutions (aspartic acid—D or glutamic acid—E) at codon site D/E163 (numbering based on C. familiaris PRNP). PrPC sequences of felids did not contain this codon (possessed asparagine—N instead); therefore, Stewart et al. [20] proposed that D/E163 provided a genetic basis for observed susceptibility differences between members of Caniformia and Feliformia. Fernandez-Borges et al. [22] further confirmed the significance of D163 using in vitro and in vivo analyses, involving a transgenic mouse model that demonstrated complete resistance to mouse prion strains despite intracerebral exposure. Further, D163 from cPrPC was demonstrated to have no effect in Drosophila; whereas N163 cPrPC caused robust neurodegenerative changes in Drosophila, indicating that D163 is a protective residue that provides intrinsic resistance to toxic conformations and increases the overall conformational stability of cPrPC [21,24].
Although the residue D163 initially was thought to be exclusive to canids, anecdotal evidence suggests that this nonsynonymous substitution appears in some chiropteran (bats) species [9,20,22]; possibly as a result of genetic drift [20]. To date, no natural or experimental prion diseases have been documented in bat species. For example, a recent study by Eraña et al. [42] provided a substantial number of prion protein gene sequences and examined the processes involved in the reactivity/conversion to misfolded proteins; however, they did not examine this in any of the dogs or bats with the D/E163 substitutions. Therefore, the goals of this study were to: (1) obtain DNA sequences for the PRNP gene from additional representatives of Chiroptera to comprehensively determine if the presence of substitutions at codon position 163 conferred a potential for susceptibility as was reported in canids, (2) survey (i.e., data mine) and compare all reported PRNP sequences (from NCBI GenBank) to those responsible for generating diseases to identify potential patterns of susceptibility or resistance, and (3), determine if DNA sequences from the PRNP gene in mammalian species provided evidence for patterns of molecular evolution that reflected either a gene tree or species tree.

2. Materials and Methods

2.1. Sampling

A total of 20 tissue samples (see Supplemental Data Table S1 for species associated with NCBI GenBank accession numbers PQ577305–PQ577324), representing the suborder Caniformia (n = 8) and order Chiroptera (n = 12), were obtained through a destructive loan process from the Robert J. Baker Genetic Resource Collection housed in the Natural Science Research Laboratory (NSRL), Museum at Texas Tech University. These samples were obtained from wild-caught individuals at various localities in Texas and Louisiana. To expand the taxonomic coverage, all prion protein gene nucleotide sequences were retrieved from NCBI GenBank (n = 12,337), and the following were filtered and removed: all genome shotgun sequences and genes for the shadow of prion protein (SPRN), prion-like doppel (PRND), among other genes. The filtered dataset was then reduced using RAxML [52], which identifies identical sequences and removes them, and a visual assessment was performed, resulting in a final dataset of 862 sequences (see Supplemental Data Table S1). Visual assessment involved screening all sequences for the codon of interest. If the codon of interest was not observed in a species, then one complete sequence was chosen at random to represent the species.

2.2. DNA Sequencing

Genomic DNA (gDNA) for 20 samples representing species in Caniformia and Chiroptera were isolated from 0.1g of liver or muscle tissue using the Qiagen DNeasy kit (Qiagen, Valencia, CA, USA). For all samples, the full-length PRNP gene (742–811 bp) was amplified using PCR (polymerase chain reaction, [53]) with the amplification primers: PRNP_F (forward, 5′-ATGGTGAAAAGCCACATAGGCGGC-3′) and PRNP_R (reverse, 5′-TCATCCCACTATCARGARAATGAG-3′). PCR reactions contained 12.5 µL HotStarTaq (Qiagen, Valencia, CA, USA), 8.3 µL distilled H2O, 0.6 µL of each primer, and 3 µL gDNA. The thermal profile parameters are as follows: hot start of 80 °C, initial denaturation at 95 °C for 2 min, followed by 34 cycles of denaturation at 95 °C for 30 s, annealing at a range of 52–54 °C for 45 s, extension at 73 °C for 1 min, and a final extension at 73 °C for 15 min.
All PCR products were purified with ExoSAP-IT (Applied Biosystems, Foster City, CA, USA). Cycle sequencing reactions used 5 µL of purified PCR products from the previous step, 2 µL ABI Prism Big Dye version 3 terminator ready reaction and buffer master mix (Applied Biosystems, Foster City, CA, USA), and 3 µL 1 µM of PRNP_F and PRNP_R, respectively. Sequencing reactions were purified using Sephadex columns (Cytiva, Marlborough, MA, USA) and centrifugation, followed by dehydration. Purified products were analyzed on an ABI 3730xl automated sequencer (Eurofins Genomics LLC, Louisville, KY, USA). Resulting sequences were aligned and proofed with Sequencher 4.10.1 software (Gene Codes Corporation, Ann Arbor, MI, USA), and chromatograms were inspected to authenticate any base changes.

2.3. Phylogenetic Analyses

A total of 882 PRNP sequences (20 generated herein and 862 obtained from NCBI GenBank) were used to construct a mammalian phylogeny. The platypus (Ornithorhynchus anatinus, EU559338) and echidna (Tachyglossus aculeatus, BK063950) were designated as outgroup taxa. Duplicate species were removed unless the sequence was representative of a species belonging to Caniformia or Chiroptera. For example, >900 sequences were returned when “Ovis aries prion protein gene” was queried on NCBI GenBank and a randomly chosen complete sequence was used as a representative for this species. Further, when querying for prion protein genes, other genes (shadow of prion protein, SPRN; prion-like doppel gene, PRND) were invariably included in the search and eliminated before processing the data. Once all non-target genes were removed, all remaining PRNP sequences were parsed into respective orders, trimmed to only include the PRNP gene, and aligned by their protein sequence to maintain the structure of the prion protein. Then all orders were assimilated and aligned by their protein sequence (if the nucleotide sequences were aligned, then the amino acid structure would be altered), resulting in an alignment of 1245 bp, which excluded stop codons. This final dataset was used for all downstream analyses.
Eighty-eight maximum likelihood (ML) models were evaluated using jModelTest-−2.1.10 [54,55]. The Akaike information criterion with a correction for finite sample sizes (AICc, [56,57]) identified the TPM2uf+I+G model of evolution (-lnL = 49,137.9405) as the most appropriate for the PRNP dataset. However, the general time reversible [58] plus proportion of invariable sites plus gamma distribution (GTR+I+Γ) model of nucleotide substitution, the most complex model, has been suggested to fit complex datasets better than simpler models [59,60,61]; therefore, we proceeded with the GTR+I+Γ model for all analyses.
A Bayesian inference (BI) model (MrBayes v3.2.6, [62]) was conducted to generate a phylogenetic tree under an ML framework and to generate posterior probability values (PPV) indicating nodal support. The GTR+I+Γ nucleotide substitution model and the following parameters were used: two independent runs with four Markov chains (one cold and three heated; MCMCMC), 10 million generations, and a sample frequency of every 1000 generations from the last nine million generated. A visual inspection of likelihood scores resulted in the first 1,000,000 trees being discarded (10% burn-in) and a consensus tree (50% majority rule) constructed from the remaining trees. PPV ≥ 0.95 was used to designate nodal support [63].

2.4. Evaluation of a Targeted Amino Acid Substitution

The program MEGA11 [64] was used to translate the nucleotide sequences to amino acids, allowing for the detection of any non-synonymous substitutions in this region. A series of 16 amino acids (DYEDRYYRENMHRYPN) based on the site of interest (N159D/E) was targeted to document the occurrence of aspartic or glutamic acids across mammalian taxa.

3. Results

3.1. Phylogenetic Analyses

A total of 882 sequences (1245 bp in length) representing 26 Orders, 132 families, and 686 species were used to recover patterns of molecular evolution in the PRNP gene. The Bayesian Inference analysis (Figure 1) produced a topology that was largely unresolved at the ordinal and familial levels, as most basal nodes were collapsed due to a lack of statistical support. Eight major Clades A–H (A, 5 Metatherian orders), (B, 20 Eutherian orders), (C, 19 Eutherian orders excluding Macroscelidea and Afrosoricidea), (D, Dermoptera, Rodentia, Scandentia, Lagomorpha, Primates, Eulipotyphla, Cetartiodactyla (Cetacea and Artiodactyla), Carnivora, Perissodactyla, and Chiroptera), (E, Dermoptera, Rodentia, Scandentia, Lagomorpha, and Primates), (F, Cetartiodactyla, Carnivora, Perissodactyla, and Chiroptera), (G, Cetartiodactyla and Carnivora), and (H, Chiroptera) were identified as possessing supported relationships. Phylogenetic placement of the orders Eulipotyphla, Tubulidentata, Hyracoidea, Sirenia, Proboscidea, Pilosa, Cingulata, Macroscelidea, and Afrosoricidea was largely unresolved, as noted by their ethereal inclusion in Clades B, C, and D.

3.2. Evaluation of a Targeted Amino Acid Substitution

Across the Mammalian orders included herein, only Carnivora, Chiroptera, Artiodactyla, and Rodentia contained species that possessed aspartic acid and/or glutamic acid at codon position 302 (D302 or E302, respectively, Table 1 and Table 2). It should be noted that codon position 159 in humans and 163 in dogs corresponds to codon position 302 as discussed herein as a result of aligning the additional mammalian sequences, which possessed varying numbers of octapeptide repeats. With the exception of the primate Loris tardigradus (glycine at 302, G302), all other mammal species possessed either an asparagine or serine at 302 (N302 or S302, respectively). Expanding on Stewart et al. [20], within Caniformia, 41 species in Canidae and Mustelidae were monomorphic for aspartic acid at site 302 (D302); with the only exception being several breeds of domestic dogs (Canis familiaris, polymorphic at codon 302—D/E302). Other Caniformia families (Ursidae, Odobenidae, Otariidae, Phocidae, Ailuridae, Procyonidae, Mephitidae) and Feliformia families (Eupleridae, Felidae, Herpestidae, Hyaenidae, and Viverridae) were monomorphic for N302. Mephitidae, which is sister to the Mustelidae [65], did not possess the D302 substitution. Further, 23 species of bats represented by Mormoopidae and Vespertilionidae also possessed D/E302. Unexpectedly, one species of Moschidae and two species of Erethizontidae were characterized by D302.
Within Chiroptera, only Mormoopidae (2 species) and Vespertilionidae (2 species) were shown to possess species containing the D302 substitution; the other 19 species of Chiroptera possessed the E302 codon (Table 1 and Table 2). In Artiodactyla, of the 9 families (117 species) examined, only one of two species in the family Moschidae (Moschus moschiferus) possessed the D302 codon. In Rodentia, only Coendou prehensilis and Erethizon dorsatum possessed codon D302, with the remaining 141 species possessing the N302 or S302 substitutions. All other mammalian groups, including rabbits, horses, and pigs, which have low susceptibility to prion diseases [44], did not possess the D or E codon.

4. Discussion

Our broad-based examination of 882 PRNP sequences revealed that only 53 of the 686 species (including 1 domesticated species, Canis familiaris, and 52 wild species of mammals) possessed either the aspartic or glutamic codon substitution (Figure 1, Table 1 and Table 2). Of these, 27 species were associated with the Carnivora (Canidae and Mustelidae); 23 species with Chiroptera (Mormoopidae and Vespertilionidae), one species of Artiodactyla (Moschidae–Moschus moschiferus), and two species of Rodentia (Erethizontidae–Coendou prehensilis and Erethizon dorsatum). Therefore, our dataset demonstrates that C. familiaris is not the only mammalian species with codon D/E159 and provides support for select, wild members of Artiodactyla, Caniformia, Chiroptera, and Rodentia to potentially possess an innate resistance to prion diseases.
The dataset examined herein (686 species) lacks sufficient taxonomic coverage (proposed 6495 mammalian species, [66]) to definitively establish any meaningful association between the aspartic acid or glutamic acid residue at human site 159, and resistance to prion diseases. However, where taxonomic coverage was sound, the large percentage of individuals lacking either of the resistant substitutions argues against inadequate sampling as a reason. Consequently, we offer four independent scenarios to potentially address these unexpected results.
  • Phylogenetic patterns revealed that the distribution of D/E159 was clearly not the product of shared ancestral/descendant relationships and provides poor evidence for a single origin involving the appearance of resistance; therefore, it may be the product of an unknown mechanism driving convergent evolution.
Phylogenetic analyses (Figure 1) depicted weak support among major groups, resulting in the “collapsing” of several branches/clades at basal nodes. For example, only certain members of the Carnivora, Chiroptera, Artiodactyla, and Rodentia possessed the amino acid substitution of interest, providing the appearance of a “random” distribution of resistance at the ordinal level. Further, the fact that these four orders are not closely related and lack phylogenetic signal, from a phylogenetic context and comparing Figure 1 to established mammalian speciation phylogenies (see [67,68,69,70] for a summary of mammalian phylogenetic relationships), supports the possibility of codon convergence in response to prion disease activity and indicates a propensity for the PRNP sequences to reflect a specific gene tree pattern of molecular evolution rather than reflecting phylogenetic relationships. In other words, it appears that the proposed resistance at human site 159 (canid site 163, site 302 herein) identified in Stewart et al. [20] is not distributed across mammalian orders due to a shared ancestry. Indeed, its presence in only a few individuals scattered across the distantly related groups, Carnivora, Chiroptera, Artiodactyla, and Rodentia, indicates that a shared evolutionary history from a common ancestor is unlikely and that an independent or repeated origin is most likely.
  • If D/E159 were the evolutionary products of a dietary response, then protection from consuming prion-infected prey or carrion would be expected in the PrP sequence of obligative carnivores (i.e., felids)
The occurrence of resistant codons across phylogenetically unrelated taxa may be the result of a molecular response to diets involving the consumption of tissue infected with prion disease. Of the 14 of 15 recognized Carnivora families (Supplemental Data Table S1; data were not available for Nandinidae) examined herein, only Canidae and Mustelidae possessed D/E159. By extension, the presence of the D/E159 substitution in wild members of the Canidae and Mustelidae could be an evolutionary adaptive form of protection against exposure to prion diseases such as CWD. For example, coyotes remain uninfected after consuming CWD-positive brain homogenates from elk, although prions from the homogenate are present in the coyote’s feces [71]. Further, Onizuka [18] suggested that herbivores possessed less resistance to prion diseases, probably because they are less exposed to prion transmission as opposed to carnivores.
The above diet hypothesis may explain the appearance of D/E159 for Canidae and Mustelidae; however, it does not explain the absence of D/E159 in other families of Caniformia (diet includes fresh flesh and scavenging) or Feliformia, which almost exclusively consume fresh flesh. One could assume that some members of Carnivora would never encounter CWD-infected individuals, considering some are omnivores (e.g., Procyonidae and Ailuridae) and others mainly inhabit aquatic environments (e.g., Odobenidae, Otariidae, and Phocidae). Members of Feliformia are obligate carnivores to some extent, yet these mammals do not possess D/E159. Hyaenidae presents an exceptional case, considering similar adaptations to canids (e.g., morphology, social hierarchy, hunting strategies, etc.) and specialization in carrion consumption.
Further, the occurrence of “resistant codons” scattered across the phylogenetically unrelated Chiroptera, Artiodactyla, and Rodentia requires alternative hypotheses. For example, the presence of D/E159 in Chiroptera may have evolved as a need for prion resistance due to their insectivorous diet. During the ingestion of insects, it is possible that bats consume adult insects that were infected during larval stages. However, even this explanation is complicated, as only two of 10 species in Mormoopidae and only 19 of 400+ species in the Vespertilionidae possessed the codon. Although most species in these two phylogenetically distant families are insectivores, the occurrence of the D/E159 in only 23 species does not suggest a strong correlation between the presence of this codon and an insectivorous diet. In addition, the fact that insectivory arose multiple times independently across Chiroptera infers a pattern of convergent evolution. Further, the geographic regions of Vespertilionid species with the substitution predominantly include not only North America, but also portions of Eurasia. The geographic region of non-substituted individuals also includes North America and Eurasia, with the observed overlap indicating no geographical significance. Although resistance to prion disease in Chiroptera has been hypothesized based on the presence of D/E159 [9,20], genotypic and in vivo challenges need to be explored in further studies to determine the breadth of resistance among taxa representative of Chiroptera and the corresponding potential resistance to prion diseases. Additionally, the presence of D159 in species (Moschus moschiferus, Coendou prehensilis, and Erethizon dorsatum) restricted to herbivory does not fit any dietary model that could explain the evolutionary need for protection against prion diseases.
Overall, the presence of N159 in 633 of the examined 686 mammalian species, especially those with carnivorous diets, invalidates the hypothesis of diet as a selective pressure and leans in favor of convergent evolution as the selective pressure that drove acquisition of N159D/E in Canidae and Mustelidae (Carnivora), Mormoopidae and Vespertilionidae (Chiroptera), Moschidae (Artiodactyla), and Erethrizontidae (Rodentia).
  • Effects of additional codon substitutions among mammals
N159D/E is not necessarily the only substitution that could confer resistance. It may be that additional codon sites play an additive role with D/E159, or that the repeat areas in the PRNP gene increase the opportunities for mutational hotspots. For example, several studies have examined breeds of dogs or species of wild canids and have found that polymorphisms at position canid N107S and R/C181H of cPrPC for Pekingese [72], Vulpes lagopus [73], Vulpes corsac [74], and Nyctereutes procyonoides [75] are consistent with polymorphisms seen in other canid species but are not shared by other mammalian species. Further, at codon 303 based on the alignment generated herein, all mammals have a Q, whereas Antrozous pallidus (BK064069), Lasionycteris noctivaga (TK94660), and Ia io (BK064208) possessed Q303H and Eptesicus fuscus (BK064945, XM054723678) and Eptesicus nilssonii (BK064950) possessed Q303R.
  • Possibility of complete resistance in the natural environment
It is unclear whether mammalian species can be broadly resistant to different TSEs. In other studies, D/E159 associated with canids did not provide complete protection against a BSE prion infection [11]. Further, when transgenic mice were inoculated with BSE and a classical scrapie strain, they displayed resistance [11,25], but exposure to bovine atypical L-BSE and other non-classical scrapie isolates resulted in susceptibility. In addition, some BSE isolates displayed a shift in their prion strain properties; therefore, it may be that a combination of different amino acid residues or possibly genes other than PRNP is needed to provide a protective effect against ruminant prions [11].
When considering the structure of cPrP, it is apparent that D159 is located on the α1-β2 loop and thereby provides structural stability and prolongs the period in prion-infected transgenic mice carrying this allele [22,23]. Further, transgenic mouse models have shown resistance to prion strains, including SSBP/1, BSE-C, CWD, sheep-BSE, cat CWD, BSE-L and atypical scrapie and demonstrated that D/E159 is protective because the alternative codon substitution susceptibility to prion transmission is increased in mice expressing cPrP-D159N [25]. Although the reverse substitution (cPrP-N159D) is not protective in human PrP [76], this substitution (cPrP-N159D) and cPrP-H177R inhibited liquid–liquid phase separation and amyloid production in human PrPC [77]. In addition, linkage disequilibrium (LD) between PRNP and prion-like protein (Doppel) gene (PRND) may play a factor in susceptibility. For example, Mesquita et al. [78] and Jeong et al. [79] demonstrated strong LD between PRNP and PRND in sheep and goats, respectively, whereas Won et al. [80,81] found evidence of a weak LD between PRNP and PRND in dogs and horses.

5. Conclusions

It is important to note that these hypotheses do not explain the level of resistance observed in all of the 53 examined species possessing the D/E159 substitution. It could be a combination of these, or even an unknown hypothesis is at play. However, it is evident based on available sequence data that the D/E159 substitution is not a product of domestication and exists in wild mammalian species. Therefore, to investigate the breadth of resistance of D/E159 of PrP, researchers need to expand inoculation trials and knock-in experiments in mice [22,37,82], as well as other studies to address sequence compatibility, mechanism of onset, and comparative models, to include the 53 species of the mammalian groups identified herein (canids, mormoopids and vesper bats, musk deer, and some rodents). These types of experiments would be highly informative to further understand the true nature of codon D/E159 beyond its documented in vitro resistance in dog breeds. For example, if future knock-in studies demonstrate a continued resistance pattern to prion diseases in vitro for these other 53 mammalian species examined herein, then the impact of those studies would provide a substantial contribution toward developing mechanistic solutions to modifying prion sensitivity in managed mammalian species. For example, the future of deer breeding operations may rely on CRISPR and cloning techniques using D/E159 as a guide to effectively prevent CWD in managed, captive deer populations and thereby greatly reduce CWD outbreaks in nearby wild deer populations and the economic loss of culling entire herds within a deer breeding operation.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ani16071059/s1, Table S1: All examined sequences with their associated taxonomic classifications and NCBI GenBank accession numbers.

Author Contributions

Conceptualization, E.A.W. and R.D.B.; methodology, R.D.B.; software, R.D.B.; validation, E.K.B., D.M.H. and R.D.B.; formal analysis, E.A.W., V.A.L., G.G.B. and S.M.R.; investigation, E.A.W.; resources, R.D.B.; data curation, E.A.W.; writing—original draft preparation, E.A.W.; writing—review and editing, E.A.W., V.A.L., G.G.B., S.M.R., E.K.B., D.M.H. and R.D.B.; visualization, R.D.B.; supervision, D.M.H. and R.D.B.; project administration, R.D.B.; funding acquisition, E.A.W., V.A.L. and R.D.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Bobby Baker Memorial Scholarship for Excellence in Scientific and Genomics Research (VAL) and a State of Texas line-item (Biological Database to RDB).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All sequence data generated for this paper were accessioned at NCBI GenBank under PQ577305–PQ577324.

Acknowledgments

Thank you to M. Buchholz for being a catalyst for prion research, without which these discoveries would have never been uncovered and investigated. Thanks to H. Garner and K. MacDonald of the Natural Science Research Laboratory at the Museum of Texas Tech University for assisting with tissue loans.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TSETransmissible spongiform encephalopathies
PRNPExon 3 region of the prion protein gene
SESpongiform encephalopathies
CJDCreutzfeldt-Jakob disease
GSSGertsmann-Sträussler-Scheinker disease
VPSPrVariable protease-sensitive prionopathy
CWDChronic wasting disease
BSEBovine spongiform encephalopathy
TMETransmissible mink encephalopathy
FSEFeline spongiform encephalopathy
CPDCamel prion disease
PrPPrion protein
PrPCNormal cellular PrP
PrPScInfectious conformation of PrP
MDCKMadin Darby canine kidney
cPrPCcanine PrPC
NMRNuclear magnetic resonance
DNADeoxyribonucleic acid
gDNAGenomic DNA
PCRPolymerase chain reaction
MLMaximum likelihood
AICcAkaike information criterion with a correction
GTR+I+Γgeneral time reversible plus proportion of invariable sites plus gamma distribution
BIBayesian inference
PPVPosterior probability values

References

  1. Sikorska, B.; Liberski, P.P. Human Prion Diseases: From Kuru to Variant Creutzfeldt-Jakob Disease. Subcell. Biochem. 2012, 65, 457–496. [Google Scholar] [CrossRef]
  2. Liberski, P.P. Historical Overview of Prion Diseases: A View from Afar. Folia Neuropathol. 2012, 50, 1–12. [Google Scholar] [PubMed]
  3. Aldhous, P. BSE: Spongiform Encephalopathy Found in Cat. Nature 1990, 345, 194. [Google Scholar] [CrossRef] [PubMed][Green Version]
  4. Brown, P.; Will, R.G.; Bradley, R.; Asher, D.M.; Detwiler, L. Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease: Background, Evolution, and Current Concerns. Emerg. Infect. Dis. 2001, 7, 6–16. [Google Scholar] [CrossRef] [PubMed]
  5. Williams, E.S.; Miller, M.W.; Kreeger, T.J.; Kahn, R.H.; Thorne, E.T. Chronic Wasting Disease of Deer and Elk: A Review with Recommendations for Management. J. Wildl. Manag. 2002, 66, 551–563. [Google Scholar] [CrossRef]
  6. Goldmann, W. PrP Genetics in Ruminant Transmissible Spongiform Encephalopathies. Vet. Res. 2008, 39, 30. [Google Scholar] [CrossRef]
  7. Babelhadj, B.; Di Bari, M.A.; Pirisinu, L.; Chiappini, B.; Gaouar, S.B.S.; Riccardi, G.; Marcon, S.; Agrimi, U.; Nonno, R.; Vaccari, G. Prion Disease in Dromedary Camels, Algeria. Emerg. Infect. Dis. 2018, 24, 1029–1036. [Google Scholar] [CrossRef]
  8. Wright, E.A.; Reddock, M.B.; Roberts, E.K.; Legesse, Y.W.; Perry, G.; Bradley, R.D. Genetic Characterization of the Prion Protein Gene in Camels (Camelus) with Comments on the Evolutionary History of Prion Disease in Cetartiodactyla. PeerJ 2024, 12, e17552. [Google Scholar] [CrossRef]
  9. Fernandez-Borges, N.; Eraña, H.; Castilla, J. Behind the Potential Evolution towards Prion Resistant Species. Prion 2018, 12, 83–87. [Google Scholar] [CrossRef]
  10. van Rheede, T.; Smolenaars, M.M.W.; Madsen, O.; de Jong, W.W. Molecular Evolution of the Mammalian Prion Protein. Mol. Biol. Evol. 2003, 20, 111–121. [Google Scholar] [CrossRef]
  11. Marin-Moreno, A.; Espinosa, J.C.; Aguilar-Calvo, P.; Fernandez-Borges, N.; Pitarch, J.L.; Gonzalez, L.; Torres, J.M. Canine D(163)-PrP Polymorphic Variant Does Not Provide Complete Protection against Prion Infection in Small Ruminant PrP Context. Sci. Rep. 2021, 11, 14309. [Google Scholar] [CrossRef]
  12. Nathanson, N.; Wilesmith, J.; Griot, C. Bovine Spongiform Encephalopathy (BSE): Causes and Consequences of a Common Source Epidemic. Am. J. Epidemiol. 1997, 145, 959–969. [Google Scholar] [CrossRef] [PubMed]
  13. Uehlinger, F.D.; Johnston, A.C.; Bollinger, T.K.; Waldner, C.L. Systematic Review of Management Strategies to Control Chronic Wasting Disease in Wild Deer Populations in North America. BMC Vet. Res. 2016, 12, 173. [Google Scholar] [CrossRef] [PubMed]
  14. Janka, J.; Maldarelli, F. Prion Diseases: Update on Mad Cow Disease, Variant Creutzfeldt-Jakob Disease, and the Transmissible Spongiform Encephalopathies. Curr. Infect. Dis. Rep. 2004, 6, 305–315. [Google Scholar] [CrossRef] [PubMed]
  15. Robinson, S.J.; Samuel, M.D.; O’Rourke, K.I.; Johnson, C.J. The Role of Genetics in Chronic Wasting Disease of North American Cervids. Prion 2012, 6, 153–162. [Google Scholar] [CrossRef]
  16. Lysek, D.A.; Schorn, C.; Nivon, L.G.; Esteve-Moya, V.; Christen, B.; Calzolai, L.; von Schroetter, C.; Fiorito, F.; Herrmann, T.; Guntert, P.; et al. Prion Protein NMR Structures of Cats, Dogs, Pigs, and Sheep. Proc. Natl. Acad. Sci. USA 2005, 102, 640–645. [Google Scholar] [CrossRef]
  17. Polymenidou, M.; Trusheim, H.; Stallmach, L.; Moos, R.; Julius, C.; Miele, G.; Lenz-Bauer, C.; Aguzzi, A. Canine MDCK Cell Lines Are Refractory to Infection with Human and Mouse Prions. Vaccine 2008, 26, 2601–2614. [Google Scholar] [CrossRef]
  18. Onizuka, K. Dogs Never Get Prion Diseases. The Entropic Landscape Analysis of Prion Proteins Answers Why. Nat. Preced. 2009, 1–10. [Google Scholar] [CrossRef]
  19. Zhang, J.; Liu, D.D. Molecular Dynamics Studies on the Structural Stability of Wild-Type Dog Prion Protein. J. Biomol. Struct. Dyn. 2011, 28, 861–869. [Google Scholar] [CrossRef]
  20. Stewart, P.; Campbell, L.; Skogtvedt, S.; Griffin, K.A.; Arnemo, J.M.; Tryland, M.; Girling, S.; Miller, M.W.; Tranulis, M.A.; Goldmann, W. Genetic Predictions of Prion Disease Susceptibility in Carnivore Species Based on Variability of the Prion Gene Coding Region. PLoS ONE 2012, 7, e50623. [Google Scholar] [CrossRef]
  21. Sanchez-Garcia, J.; Jensen, K.; Zhang, Y.; Rincon-Limas, D.E.; Fernandez-Funez, P. A Single Amino Acid (Asp159) from the Dog Prion Protein Suppresses the Toxicity of the Mouse Prion Protein in Drosophila. Neurobiol. Dis. 2016, 95, 204–209. [Google Scholar] [CrossRef]
  22. Fernandez-Borges, N.; Parra, B.; Vidal, E.; Eraña, H.; Sanchez-Martin, M.A.; de Castro, J.; Elezgarai, S.R.; Pumarola, M.; Mayoral, T.; Castilla, J. Unraveling the Key to the Resistance of Canids to Prion Diseases. PLoS Pathog. 2017, 13, e1006716. [Google Scholar] [CrossRef] [PubMed]
  23. Kim, D.J.; Kim, Y.C.; Kim, A.D.; Jeong, B.H. Novel Polymorphisms and Genetic Characteristics of the Prion Protein Gene (PRNP) in Dogs—A Resistant Animal of Prion Disease. Int. J. Mol. Sci. 2020, 21, 4160. [Google Scholar] [CrossRef] [PubMed]
  24. Sanchez-Garcia, J.; Fernandez-Funez, P. D159 and S167 Are Protective Residues in the Prion Protein from Dog and Horse, Two Prion-Resistant Animals. Neurobiol. Dis. 2018, 119, 1–12. [Google Scholar] [CrossRef] [PubMed]
  25. Vidal, E.; Fernandez-Borges, N.; Eraña, H.; Parra, B.; Pintado, B.; Sanchez-Martin, M.A.; Charco, J.M.; Ordonez, M.; Perez-Castro, M.A.; Pumarola, M.; et al. Dogs Are Resistant to Prion Infection, Due to the Presence of Aspartic or Glutamic Acid at Position 163 of Their Prion Protein. FASEB J. 2020, 34, 3969–3982. [Google Scholar] [CrossRef]
  26. Perez, D.R.; Damberger, F.F.; Wuthrich, K. Horse Prion Protein NMR Structure and Comparisons with Related Variants of the Mouse Prion Protein. J. Mol. Biol. 2010, 400, 121–128. [Google Scholar] [CrossRef]
  27. Zhang, J. The Structural Stability of Wild-Type Horse Prion Protein. J. Biomol. Struct. Dyn. 2011, 29, 369–377. [Google Scholar] [CrossRef]
  28. Zhang, J. The Nature of the Infectious Agents: PrP Models of Resistant Species to Prion Diseases (Dog, Rabbit and Horses). arXiv 2011, arXiv:1106.4628. [Google Scholar] [CrossRef]
  29. Kim, Y.C.; Jeong, B.H. The First Report of Polymorphisms and Genetic Characteristics of the Prion Protein Gene (PRNP) in Horses. Prion 2018, 12, 245–252. [Google Scholar] [CrossRef]
  30. Vorberg, I.; Groschup, M.H.; Pfaff, E.; Priola, S.A. Multiple Amino Acid Residues within the Rabbit Prion Protein Inhibit Formation of Its Abnormal Isoform. J. Virol. 2003, 77, 2003–2009. [Google Scholar] [CrossRef]
  31. Khan, M.Q.; Sweeting, B.; Mulligan, V.K.; Arslan, P.E.; Cashman, N.R.; Pai, E.F.; Chakrabartty, A. Prion Disease Susceptibility Is Affected by Beta-Structure Folding Propensity and Local Side-Chain Interactions in PrP. Proc. Natl. Acad. Sci. USA 2010, 107, 19808–19813. [Google Scholar] [CrossRef] [PubMed]
  32. Espinosa, J.C.; Marin-Moreno, A.; Aguilar-Calvo, P.; Benestad, S.L.; Andreoletti, O.; Torres, J.M. Porcine Prion Protein as a Paradigm of Limited Susceptibility to Prion Strain Propagation. J. Infect. Dis. 2021, 223, 1103–1112. [Google Scholar] [CrossRef] [PubMed]
  33. Fernandez-Funez, P.; Zhang, Y.; Sanchez-Garcia, J.; Jensen, K.; Zou, W.Q.; Rincon-Limas, D.E. Pulling Rabbits to Reveal the Secrets of the Prion Protein. Commun. Integr. Biol. 2011, 4, 262–266. [Google Scholar] [CrossRef] [PubMed]
  34. Qing, L.L.; Zhao, H.; Liu, L.L. Progress on Low Susceptibility Mechanisms of Transmissible Spongiform Encephalopathies. Zool. Res. 2014, 35, 436–445. [Google Scholar]
  35. Myers, R.; Cembran, A.; Fernandez-Funez, P. Insight from Animals Resistant to Prion Diseases: Deciphering the Genotype-Morphotype-Phenotype Code for the Prion Protein. Front. Cell. Neurosci. 2020, 14, 254. [Google Scholar] [CrossRef]
  36. Cembran, A.; Fernandez-Funez, P. Conformational Dynamics as an Intrinsic Determinant of Prion Protein Misfolding and Neurotoxicity. Neural Regen. Res. 2024, 19, 2095–2096. [Google Scholar] [CrossRef]
  37. Chianini, F.; Fernandez-Borges, N.; Vidal, E.; Gibbard, L.; Pintado, B.; de Castro, J.; Priola, S.A.; Hamilton, S.; Eaton, S.L.; Finlayson, J.; et al. Rabbits Are Not Resistant to Prion Infection. Proc. Natl. Acad. Sci. USA 2012, 109, 5080–5085. [Google Scholar] [CrossRef]
  38. Angelli, J.N.; Passos, Y.M.; Brito, J.M.; Silva, J.L.; Cordeiro, Y.; Vieira, T.C. Rabbit PrP Is Partially Resistant to in Vitro Aggregation Induced by Different Biological Cofactors. Front. Neurosci. 2021, 15, 689315. [Google Scholar] [CrossRef]
  39. Westaway, D.; Zuliani, V.; Cooper, C.M.; Da Costa, M.; Neuman, S.; Jenny, A.L.; Detwiler, L.; Prusiner, S.B. Homozygosity for Prion Protein Alleles Encoding Glutamine-171 Renders Sheep Susceptible to Natural Scrapie. Genes Dev. 1994, 8, 959–969. [Google Scholar] [CrossRef]
  40. Bossers, A.; Schreuder, B.E.; Muileman, I.H.; Belt, P.B.; Smits, M.A. PrP Genotype Contributes to Determining Survival Times of Sheep with Natural Scrapie. J. Gen. Virol. 1996, 77, 2669–2673. [Google Scholar] [CrossRef]
  41. Dubois, M.A.; Sabatier, P.; Durand, B.; Calavas, D.; Ducrot, C.; Chalvet-Monfray, K. Multiplicative Genetic Effects in Scrapie Disease Susceptibility. C. R. Biol. 2002, 325, 565–570. [Google Scholar] [CrossRef] [PubMed]
  42. Eraña, H.; Sampedro-Torres-Quevedo, C.; Charco, J.M.; Diaz-Dominguez, C.M.; Peccati, F.; San-Juan-Ansoleaga, M.; Vidal, E.; Goncalves-Anjo, N.; Perez-Castro, M.A.; Gonzalez-Miranda, E.; et al. A Protein Misfolding Shaking Amplification-Based Method for the Spontaneous Generation of Hundreds of Bona Fide Prions. Nat. Commun. 2024, 15, 2112. [Google Scholar] [CrossRef] [PubMed]
  43. Belt, P.B.; Muileman, I.H.; Schreuder, B.E.; Bos-de Ruijter, J.; Gielkens, A.L.; Smits, M.A. Identification of Five Allelic Variants of the Sheep PrP Gene and Their Association with Natural Scrapie. J. Gen. Virol. 1995, 76, 509–517. [Google Scholar] [CrossRef]
  44. Zhang, J.; Wang, F.; Chatterjee, S. Molecular Dynamics Studies on the Buffalo Prion Protein. J. Biomol. Struct. Dyn. 2016, 34, 762–777. [Google Scholar] [CrossRef] [PubMed][Green Version]
  45. Ryder, S.J.; Hawkins, S.A.; Dawson, M.; Wells, G.A. The Neuropathology of Experimental Bovine Spongiform Encephalopathy in the Pig. J. Comp. Pathol. 2000, 122, 131–143. [Google Scholar] [CrossRef]
  46. Castilla, J.; Gutierrez-Adan, A.; Brun, A.; Doyle, D.; Pintado, B.; Ramirez, M.A.; Salguero, F.J.; Parra, B.; Segundo, F.D.; Sanchez-Vizcaino, J.M.; et al. Subclinical Bovine Spongiform Encephalopathy Infection in Transgenic Mice Expressing Porcine Prion Protein. J. Neurosci. 2004, 24, 5063–5069. [Google Scholar] [CrossRef]
  47. Nisbet, R.M.; Harrison, C.F.; Lawson, V.A.; Masters, C.L.; Cappai, R.; Hill, A.F. Residues Surrounding the Glycosylphosphatidylinositol Anchor Attachment Site of PrP Modulate Prion Infection: Insight from the Resistance of Rabbits to Prion Disease. J. Virol. 2010, 84, 6678–6686. [Google Scholar] [CrossRef]
  48. Fernández-Borges, N.; Chianini, F.; Eraña, H.; Vidal, E.; Eaton, S.L.; Pintado, B.; Finlayson, J.; Dagleish, M.P.; Castilla, J. Naturally Prion Resistant Mammals: A Utopia? Prion 2012, 6, 425–429. [Google Scholar] [CrossRef][Green Version]
  49. Vidal, E.; Fernandez-Borges, N.; Pintado, B.; Ordonez, M.; Marquez, M.; Fondevila, D.; Torres, J.M.; Pumarola, M.; Castilla, J. Bovine Spongiform Encephalopathy Induces Misfolding of Alleged Prion-Resistant Species Cellular Prion Protein without Altering Its Pathobiological Features. J. Neurosci. 2013, 33, 7778–7786. [Google Scholar] [CrossRef]
  50. Vidal, E.; Fernandez-Borges, N.; Pintado, B.; Eraña, H.; Ordonez, M.; Marquez, M.; Chianini, F.; Fondevila, D.; Sanchez-Martin, M.A.; Andreoletti, O.; et al. Transgenic Mouse Bioassay: Evidence That Rabbits Are Susceptible to a Variety of Prion Isolates. PLoS Pathog. 2015, 11, e1004977. [Google Scholar] [CrossRef]
  51. Bian, J.; Khaychuk, V.; Angers, R.C.; Fernandez-Borges, N.; Vidal, E.; Meyerett-Reid, C.; Kim, S.; Calvi, C.L.; Bartz, J.C.; Hoover, E.A.; et al. Prion Replication without Host Adaptation during Interspecies Transmissions. Proc. Natl. Acad. Sci. USA 2017, 114, 1141–1146. [Google Scholar] [CrossRef]
  52. Stamatakis, A. RAxML Version 8: A Tool for Phylogenetic Analysis and Post-Analysis of Large Phylogenies. Bioinformatics 2014, 30, 1312–1313. [Google Scholar] [CrossRef] [PubMed]
  53. Saiki, R.K.; Gelfand, D.H.; Stoffel, S.; Scharf, S.J.; Higuchi, R.; Horn, G.T.; Mullis, K.B.; Erlich, H.A. Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase. Science 1988, 239, 487–491. [Google Scholar] [CrossRef] [PubMed]
  54. Guindon, S.; Gascuel, O. A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood. Syst. Biol. 2003, 52, 696–704. [Google Scholar] [CrossRef] [PubMed]
  55. Darriba, D.; Taboada, G.L.; Doallo, R.; Posada, D. JModelTest 2: More Models, New Heuristics and Parallel Computing. Nat. Methods 2012, 9, 772. [Google Scholar] [CrossRef]
  56. Hurvich, C.M.; Tsai, C. Regression and Time Series Model Selection in Small Samples. Biometrika 1989, 76, 297–307. [Google Scholar] [CrossRef]
  57. Burnham, K.P.; Anderson, D.R. Multimodel Inference: Understanding AIC and BIC in Model Selection. Sociol. Methods Res. 2004, 33, 261–304. [Google Scholar] [CrossRef]
  58. Tavaré, S. Some Probabilistic and Statistical Problems on the Analysis of DNA Sequence. Lect. Notes Math. Life Sci. 1986, 17, 57. [Google Scholar]
  59. Jayaswal, V.; Jermiin, L.S.; Poladian, L.; Robinson, J. Two Stationary Nonhomogeneous Markov Models of Nucleotide Sequence Evolution. Syst. Biol. 2011, 60, 74–86. [Google Scholar] [CrossRef]
  60. Sumner, J.G.; Jarvis, P.D.; Fernández-Sánchez, J.; Kaine, B.T.; Woodhams, M.D.; Holland, B.R. Is the General Time-Reversible Model Bad for Molecular Phylogenetics? Syst. Biol. 2012, 61, 1069–1074. [Google Scholar] [CrossRef]
  61. Arenas, M. Trends in Substitution Models of Molecular Evolution. Front. Genet. 2015, 6, 319. [Google Scholar] [CrossRef] [PubMed]
  62. Ronquist, F.; Teslenko, M.; van der Mark, P.; Ayres, D.L.; Darling, A.; Hohna, S.; Larget, B.; Liu, L.; Suchard, M.A.; Huelsenbeck, J.P. MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice across a Large Model Space. Syst. Biol. 2012, 61, 539–542. [Google Scholar] [CrossRef] [PubMed]
  63. Huelsenbeck, J.P.; Larget, B.; Miller, R.E.; Ronquist, F. Potential Applications and Pitfalls of Bayesian Inference of Phylogeny. Syst. Biol. 2002, 51, 673–688. [Google Scholar] [CrossRef] [PubMed]
  64. Tamura, K.; Stecher, G.; Kumar, S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol. Biol. Evol. 2021, 38, 3022–3027. [Google Scholar] [CrossRef]
  65. Dragoo, J.W.; Honeycutt, R.L. Systematics of Mustelid-like Carnivores. J. Mammal. 1997, 78, 426–443. [Google Scholar] [CrossRef]
  66. Burgin, C.J.; Colella, J.P.; Kahn, P.L.; Upham, N.S. How Many Species of Mammals Are There? J. Mammal. 2018, 99, 1–14. [Google Scholar] [CrossRef]
  67. Bininda-Emonds, O.R.; Cardillo, M.; Jones, K.E.; MacPhee, R.D.; Beck, R.M.; Grenyer, R.; Price, S.A.; Vos, R.A.; Gittleman, J.L.; Purvis, A. The Delayed Rise of Present-Day Mammals. Nature 2007, 446, 507–512. [Google Scholar] [CrossRef]
  68. Roberts, E.K.; Wright, E.A.; Worsham, A.E.; Hardy, D.M.; Bradley, R.D. Gamete Recognition Gene Divergence Yields a Robust Eutherian Phylogeny across Taxonomic Levels. Diversity 2023, 15, 1145. [Google Scholar] [CrossRef]
  69. Roberts, E.K.; Tardif, S.; Wright, E.A.; Platt, R.N.; Bradley, R.D.; Hardy, D.M. Rapid Divergence of a Gamete Recognition Gene Promoted Macroevolution of Eutheria. Genome Biol. 2022, 23, 155. [Google Scholar] [CrossRef]
  70. Upham, N.S.; Esselstyn, J.A.; Jetz, W. Inferring the Mammal Tree: Species-Level Sets of Phylogenies for Questions in Ecology, Evolution, and Conservation. PLoS Biol. 2019, 17, e3000494. [Google Scholar] [CrossRef]
  71. Nichols, T.A.; Fischer, J.W.; Spraker, T.R.; Kong, Q.; VerCauteren, K.C. CWD Prions Remain Infectious after Passage through the Digestive System of Coyotes (Canis latrans). Prion 2015, 9, 367–375. [Google Scholar] [CrossRef] [PubMed]
  72. Wu, C.; Pang, W.; Yang, J.; Zhou, X.; Zhao, D. Amino Acid Sequence of the Pekingese Dog Prion Protein Gene. Xenotransplantation 2006, 13, 471–474. [Google Scholar] [CrossRef] [PubMed]
  73. Wan, J.; Bai, X.; Liu, W.; Xu, J.; Xu, M.; Gao, H. Polymorphism of Prion Protein Gene in Arctic Fox (Vulpes lagopus). Mol. Biol. Rep. 2009, 36, 1299–1303. [Google Scholar] [CrossRef] [PubMed]
  74. Yang, X.H.; Xiao, K.; Wu, Y.; Gao, L.; Chen, D.; Dong, X.P.; Shi, Q. Cloning and Analysis of PRNP Gene of Vulpes corsac in Qinghai Plateau, China. Prion 2020, 14, 20–23. [Google Scholar] [CrossRef]
  75. Jo, W.S.; Kim, Y.C.; Oem, J.K.; Jeong, B.H. First Report of Structural Characteristics and Polymorphisms of the Prion Protein Gene in Raccoon Dogs: The Possibility of Prion Disease-Resistance. Front. Vet. Sci. 2022, 9, 989352. [Google Scholar] [CrossRef]
  76. Myers, R.R.; Sanchez-Garcia, J.; Leving, D.C.; Melvin, R.G.; Fernandez-Funez, P. New Drosophila Models to Uncover the Intrinsic and Extrinsic Factors That Mediate the Toxicity of the Human Prion Protein. Dis. Model. Mech. 2022, 15, dmm049184. [Google Scholar] [CrossRef]
  77. Li, X.N.; Gao, Y.; Li, Y.; Yin, J.X.; Yi, C.W.; Yuan, H.Y.; Huang, J.J.; Wang, L.Q.; Chen, J.; Liang, Y. Arg177 and Asp159 from Dog Prion Protein Slow Liquid-Liquid Phase Separation and Inhibit Amyloid Formation of Human Prion Protein. J. Biol. Chem. 2023, 299, 105329. [Google Scholar] [CrossRef]
  78. Mesquita, P.; Batista, M.; Marques, M.R.; Santos, I.C.; Pimenta, J.; Silva Pereira, M.; Carolino, I.; Santos Silva, F.; Oliveira Sousa, M.C.; Gama, L.T.; et al. Prion-like Doppel Gene Polymorphisms and Scrapie Susceptibility in Portuguese Sheep Breeds. Anim. Genet. 2010, 41, 311–314. [Google Scholar] [CrossRef]
  79. Jeong, M.J.; Kim, Y.C.; Jeong, B.H. Prion-like Protein Gene (PRND) Polymorphisms Associated with Scrapie Susceptibility in Korean Native Black Goats. PLoS ONE 2018, 13, e0206209. [Google Scholar] [CrossRef]
  80. Won, S.Y.; Kim, Y.C.; Do, K.; Jeong, B.H. Absence of Strong Genetic Linkage Disequilibrium between Single Nucleotide Polymorphisms (SNPs) in the Prion Protein Gene (PRNP) and the Prion-like Protein Gene (PRND) in the Horse, a Prion-Resistant Species. Genes 2020, 11, 518. [Google Scholar] [CrossRef]
  81. Won, S.Y.; Kim, Y.C.; Kim, K.; Kim, A.D.; Jeong, B.H. The First Report of Polymorphisms and Genetic Features of the Prion-like Protein Gene (PRND) in a Prion Disease-Resistant Animal, Dog. Int. J. Mol. Sci. 2019, 20, 1404. [Google Scholar] [CrossRef]
  82. Otero, A.; Hedman, C.; Fernández-Borges, N.; Eraña, H.; Marín, B.; Monzón, M.; Sánchez-Martín, M.A.; Nonno, R.; Badiola, J.J.; Bolea, R. A Single Amino Acid Substitution, Found in Mammals with Low Susceptibility to Prion Diseases, Delays Propagation of Two Prion Strains in Highly Susceptible Transgenic Mouse Models. Mol. Neurobiol. 2019, 56, 6501–6511. [Google Scholar] [CrossRef]
Figure 1. Phylogeny of the exon 3 region of the prion protein gene using 882 mammalian sequences. Bayesian posterior probability values represent ≥95% nodal support. Phylogenetic groups shown in bold text indicate the occurrence of N159D/E.
Figure 1. Phylogeny of the exon 3 region of the prion protein gene using 882 mammalian sequences. Bayesian posterior probability values represent ≥95% nodal support. Phylogenetic groups shown in bold text indicate the occurrence of N159D/E.
Animals 16 01059 g001
Table 1. All mammal species, except those listed below, possess an asparagine (N) at codon 159. Within the Order Carnivora and Chiroptera, there were a few cases where certain species possess the codon substitution from asparagine to aspartic (D) or glutamic (E) acids. Sample size refers to the number of available sequences, not the number of species.
Table 1. All mammal species, except those listed below, possess an asparagine (N) at codon 159. Within the Order Carnivora and Chiroptera, there were a few cases where certain species possess the codon substitution from asparagine to aspartic (D) or glutamic (E) acids. Sample size refers to the number of available sequences, not the number of species.
OrderFamilySpeciesSample SizeAmino Acid
CarnivoraCanidaeDomestic dog and dingo, Canis familiaris66D/E
Coyote, C. latrans5D
Grey wolf, C. lupus4D
Maned wolf, Chrysocyon brachyurus1D
African wild dog, Lycaon pictus1D
Side-striped jackal, Lupulella adustus1D
Black-backed jackal, L. mesomelas1D
Common raccoon dog, Nyctereutes procyonoides4D
Bat-eared fox, Otocyon megalotis1D
Bush dog, Speothos venaticus1D
Grey Fox, Urocyon cinereoargenteus2D
Island fox, U. littoralis1D
Corsac fox, V. corsac1D
Tibetan fox, Vulpes ferrilata1D
Arctic fox, V. lagopus3D
Swift fox, V. velox1D
Red fox, Vulpes vulpes4D
Fennec fox, V. zerda1D
MustelidaeTayra, Eira barbara1D
Wolverine, Gulo gulo3D
Yellow-throated marten, Martes flavigula1D
Beech marten, M. foina1D
European pine marten, M. martes1D
Sable, M. zibellina1D
Honey badger, Mellivora capensis1D
Fisher, Pekania pennanti1D
American badger, Taxidea taxus2D
ChiropteraMormoopidaeMesoamerican common mustached bat, Pteronotus mesoamericanus2D
Parnell’s mustached bat, P. parnellii1D
VespertilionidaeHoary bat, Aeorestes cinereus2E
Pallid bat, Antrozous pallidus1E
Rafinesque’s big-eared bat, Corynorhinus rafinesquii2E
Townsend’s big-eared bat, C. townsendii2E
Western yellow bat, Dasypterus xanthinus2E
Big brown bat, Eptesicus fuscus2E
Northern bat, E. nilssonii1E
Great evening bat, Ia io1E
Silver-haired bat, Lasionycteris noctivaga1E
Eastern red bat, Lasiurus borealis2E
Western red bat, L. frantzi1E
Brandt’s bat, Myotis brandtii1D
Little brown bat, M. lucifugus2D
Birdlike noctule, Nyctalus aviator1E
Evening bat, Nycticeius humeralis1E
Canyon bat, Parastrellus hesperus1E
Tricolored bat, Perimyotis flavus1E
Kuhl’s pipistrelle, Pipistrellus kuhlii2E
Common pipistrelle, P. pipistrellus2E
Brown long-eared bat, Plecotus auritus1E
Parti-colored bat, Vespertilio murinus1E
ArtiodactylaMoschidaeSiberian musk deer, Moschus moschiferus1D
RodentiaErethizontidaeBrazilian porcupine, Coendou prehensilis1D
North American porcupine, Erethizon dorsatum1D
Table 2. Sequence alignments of the 53 species characterized by D/E159 (in bold) using the human prion protein (PrP) sequence as a reference. Dashes represent no change from the human PrP sequence.
Table 2. Sequence alignments of the 53 species characterized by D/E159 (in bold) using the human prion protein (PrP) sequence as a reference. Dashes represent no change from the human PrP sequence.
Species144145146147148149150151152153154155156157158159160161
1Human, Homo sapiensDYEDRYYRENMHRYPNQV
2Domestic dog and dingo, Canis familiaris-----------Y---D--
3Coyote, C. latrans-----------Y---D--
4Grey wolf, C. lupus-----------Y---D--
5Maned wolf, Chrysocyon brachyurus-----------Y---D--
6African wild dog, Lycaon pictus-----------Y---D--
7Side-striped jackal, Lupulella adustus-----------Y---D--
8Black-backed jackal, L. mesomelas-----------Y---D--
9Common raccoon dog, Nyctereutes procyonoides-----------Y---D--
10Bat-eared fox, Otocyon megalotis-----------Y---D--
11Bush dog, Speothos venaticus-----------Y---D--
12Grey Fox, Urocyon cinereoargenteus-----------Y---D--
13Island fox, U. littoralis-----------Y---D--
14Corsac fox, Vulpes corsac-----------Y---D--
15Tibetan fox, V. ferrilata-----------Y---D--
16Arctic fox, V. lagopus-----------Y---D--
17Swift fox, V. velox-----------Y---D--
18Red fox, V. vulpes-----------Y---D--
19Fennec fox, V. zerda-----------Y---D--
20Tayra, Eira barbara---------------D--
21Wolverine, Gulo gulo---------------D--
22Yellow-throated marten, Martes flavigula---------------D--
23Beech marten, M. foina---------------D--
24European pine marten, M. martes---------------D--
25Sable, M. zibellina---------------D--
26Honey badger, Mellivora capensis---------------D--
27Fisher, Pekania pennanti---------------D--
28American badger, Taxidea taxus---------------D--
29Mesoamerican common mustached bat, Pteronotus mesoamericanus-------------F-D--
30Parnell’s mustached bat, P. parnellii-------------F-D--
31Hoary bat, Aeorestes cinereusE----------N-F-E--
32Pallid bat, Antrozous pallidusE----------N-F-EH-
33Rafinesque’s big-eared bat, Corynorhinus rafinesquiiE----------N-F-E--
34Townsend’s big-eared bat, C. townsendiiE----------N-F-E--
35Western yellow bat, Dasypterus xanthinusE----------N-F-E--
36Big brown bat, Eptesicus fuscusE----------N-F-ER-
37Northern bat, E. nilssoniiE----------N-F-ER-
38Great evening bat, Ia ioE----------N-F-EH-
39Silver-haired bat, Lasionycteris noctivagaE----------N-F-EH-
40Eastern red bat, Lasiurus borealisE----------N-F-E--
41Western red bat, L. frantziE----------N-F-E--
42Brandt’s bat, Myotis brandtiiE----------N-F-D--
43Little brown bat, M. lucifugusE----------N-F-D--
44Birdlike noctule, Nyctalus aviatorE----------N-F-E--
45Evening bat, Nycticeius humeralisE----------N-F-E--
46Canyon bat, Parastrellus hesperusE----------N-F-E--
47Tricolored bat, Perimyotis flavusE----------N-F-E--
48Kuhl’s pipistrelle, Pipistrellus kuhliiE----------N-F-E--
49Common pipistrelle, P. pipistrellusE----------N-F-E--
50Brown long-eared bat, Plecotus auritusE----------N-F-E--
51Parti-colored bat, Vespertilio murinusE----------N-F-E--
52Siberian musk deer, Moschus moschiferus-----------Y---D--
53Brazilian porcupine, Coendou prehensilis-----------Y---D--
54North American porcupine, Erethizon dorsatum-----------Y---D--
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wright, E.A.; Lacy, V.A.; Brugette, G.G.; Roberts, S.M.; Brookover, E.K.; Hardy, D.M.; Bradley, R.D. Prion Protein Codon Implicated in Resistance in Dogs Detected in Non-Domesticated Members of Mammalia. Animals 2026, 16, 1059. https://doi.org/10.3390/ani16071059

AMA Style

Wright EA, Lacy VA, Brugette GG, Roberts SM, Brookover EK, Hardy DM, Bradley RD. Prion Protein Codon Implicated in Resistance in Dogs Detected in Non-Domesticated Members of Mammalia. Animals. 2026; 16(7):1059. https://doi.org/10.3390/ani16071059

Chicago/Turabian Style

Wright, Emily A., Vivienne A. Lacy, Georgina G. Brugette, Savannah M. Roberts, Emma K. Brookover, Daniel M. Hardy, and Robert D. Bradley. 2026. "Prion Protein Codon Implicated in Resistance in Dogs Detected in Non-Domesticated Members of Mammalia" Animals 16, no. 7: 1059. https://doi.org/10.3390/ani16071059

APA Style

Wright, E. A., Lacy, V. A., Brugette, G. G., Roberts, S. M., Brookover, E. K., Hardy, D. M., & Bradley, R. D. (2026). Prion Protein Codon Implicated in Resistance in Dogs Detected in Non-Domesticated Members of Mammalia. Animals, 16(7), 1059. https://doi.org/10.3390/ani16071059

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop